Clinical Trials Directory

Trials / Completed

CompletedNCT05362734

Freeze All Strategy Versus Fresh Embryo Transfer After GnRH Analogue Trigger

Status
Completed
Phase
Study type
Observational
Enrollment
1,396 (actual)
Sponsor
Istituto Clinico Humanitas · Academic / Other
Sex
Female
Age
20 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Ovarian hyperstimulation syndrome (OHSS) is one of the most dangerous complications of assisted reproduction technology (ART), described in approximatively 3 to 10% of stimulation cycles although an underestimation of the real incidence has been suggested. The use in clinical practice of GnRH antagonist has made it possible to perform the trigger with GnRH analogues, with the advantage of considerably reducing the risk of OHSS.

Detailed description

The main concerns about the trigger with analogue are about obstetric outcomes, since it may increase the Abortion Rate (AR) and reduce the Ongoing Pregnancy Rate (OPR) due to luteal phase deficiency, and on the other hand about oocyte quality and competence. While in order to maximize the chance of pregnancy at fresh embryo transfer after GnRHa trigger, several studies have focused on the importance of luteal phase support, other authors suggest that the best strategy is freeze-all: cryopreservation of all the obtained embryos and subsequent single embryo transfers. However, data about oocyte quality, retrieval rate, pregnancy rate and reduced occurrence of complications such as OHSS, especially on the very first embryo transfer, are still scarce.

Conditions

Interventions

TypeNameDescription
BEHAVIORALobstetric outcomes after fresh versus cryopreserved embryo transfermeasure of ongoing pregnancy rate, delivery rate, abortion rate, ectopic pregnancy rate, multiple birth rate, ovarian hyperstimulation syndrome incidence, drop out rate

Timeline

Start date
2012-01-01
Primary completion
2020-12-31
Completion
2020-12-31
First posted
2022-05-05
Last updated
2023-07-07

Source: ClinicalTrials.gov record NCT05362734. Inclusion in this directory is not an endorsement.